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Our laboratory’s ability to induce deep hypometabolism (DH) via an injection of
adenosine monophosphate (5’-AMP) followed by placement in an ambient temperature (Ta)
around 15oC currently can last about 3-9 hours. While we have insight into how 5’-AMP
induced hypometabolism is initiated, it remains unclear how arousal from hypometabolism
is controlled. Other laboratory members have been unable to prolong this process safely and
effectively with previous attempts of re-injecting a dose of 5’-AMP upon arousal or by
decreasing the Ta. While these methods worked in suppressing arousal, the mortality rate is
also increased. To gather a better understanding of the process, a metabolic panel from
serum samples was run giving insight into possible biochemical events occurring from
euthermia to DH to spontaneous arousal and back to euthermia. Analyzing this data revealed
many changes in metabolites. A few metabolites that stood out such as glucose and
pyruvate did not alter the outcome in arousal rate over saline injection. Additional
metabolite analysis revealed that an amino acid, arginine, was significantly reduced during
DH. This amino acid seems to be a key component in prolonging our process possibly due to
its intricate role in the urea cycle. Supplemental arginine is clearly more beneficial both in
suppressing arousal and increasing the survival rate after 12 hours in DH.
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CHAPTER ONE
Introduction
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Animals are most commonly segregated into two categories: warm- and coldblooded. Warm-blooded animals such as mammals and birds (also known as endotherms)
maintain their core body temperature at an optimally efficient degree, and for humans this is
98.6oF or 37oC. In contrast, the core body temperature of cold-blooded animals such as
reptiles and amphibians (also known as ectotherms) will fluctuate over a range, depending in
part on their environmental temperature. For humans and other endotherms, this
maintenance comes at an enormous energy cost compared to similarly sized ectotherms
(Heldmaier et al., 2004; Else and Hubert, 1981). Mammals large and small alike go
through daily sleep and awake cycles, during which the metabolic rate and body temperature
drop slightly when resting (Heldmaier et al., 2004). However this drop is miniscule (less
than 1oC) compared to the reduction that occurs in daily torpor or hibernation (Lyman,
1982; Geiser and Ruf, 1995). Animals that enter hibernation go through a prolonged
hypometabolic state, which allows their body temperature to drop to around that of their
environment (Heldmaier et al., 2004). For some hibernators, such as the arctic ground
squirrel, the core body temperature at hibernation is just above freezing (Barnes 1989).
Similarly, there are animals that undergo daily bouts of torpor, which is a less severe form of
hypometabolic state that results in a lowering of the core body temperature (Lyman, 1982).
Both hibernation and torpor involve the same 4 stages: entrance into hibernation/torpor,
maintenance at the sub-basal metabolic rate, arousal from the deep hypometabolism, and a
period at euthermia (Heldmaier et al., 2004). Another commonality between daily torpor
and hibernation is that as these animals are ready to end their hypometabolic state, their
bodies start the gradual rewarming process (arousal) that returns the body to euthermic
temperature and normal metabolic activity (Heldmaier et al., 2004). The difference
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between the hibernation and the torpor states lies in the second phase (maintenance) or the
amount of time spent being metabolically depressed; hibernators can exist for days or even
weeks at a time, whereas animals undergoing torpor fluctuate between normal function and
the hypometabolic state daily (Geiser and Ruf, 1995). In other words, torpor is a daily, less
severe form of hypometabolism. These physiological conditions have been observed in most
of the mammalian orders in both small and large animals, from bats to lemurs to squirrels
(Heldmaier et al., 2004; Carroll, 1997). The lemurs are old world primates and they are
known to hibernate during periods of metabolic stress (Kobbe et al., 2009). Since humans
are also primates it should be possible for humans to undergo either daily torpor and/or
hibernation, but if/how this is possible is unknown (Heldmaier et al., 2004; Carroll, 1997).
The reason we study these processes is to unlock the benefits of hypometabolism so that
they can be applied to non-hibernating mammals like humans. The possibilities are vast; this
research could potentially help with anything from increasing the survival rates in trauma
patients by reducing their body’s metabolic need, to reducing metabolic disorders such as
obesity by changing the preferred fuel source from glucose in euthermia to fats in
hibernation, to something as remote as revolutionizing space travel by allowing the transport
of humans in the hypometabolic state (Andrews, 2007). Also, understanding and exploiting
hibernation in humans could be the answer to that which people covet most: the fountain of
youth (Lyman et al., 1981). It has been suggested that hibernation could have similar
benefits to prolonging life as seen by the practice of caloric restriction (Andrews, 2007).
Unfortunately, for the most part, the process of hibernation is not well understood and is still
being extensively researched.
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Our laboratory has discovered that a naturally produced metabolite, 5’adenosine
monophosphate (5’-AMP), can be used to induce a torpor-like state in mice without any
apparent relation to either size or sex of the animal (Zhang et al., 2006). By injecting 0.5
mg/gram body weight (mg/gw) of 5’-AMP and placing the mice into an incubator with an
ambient temperature (Ta) around 15oC, the mice will remain in this deep hypometabolic
state anywhere between 3-9 hours. The reason for the range in the amount of time down is
due to the fact that the arousal process from this hypometabolic state appears to be
completely spontaneous. Attempts by other investigators in the laboratory to extend this
hypometabolic process were largely unsuccessful due to high mortality rate. Approaches to
extend the length of this hypometabolic process include increased dosage of 5’-AMP or
additional injections of 5’-AMP when animals were about to arouse. Increasing the dose of
5’-AMP by several folds did not extend the length of this hypometabolic state. Giving
additional 5’-AMP when an animal was about to arouse led to high mortality after the mouse
had been in hypometabolism for 14-18 hours. However, animals that have returned to
euthermia can undergo another episode of 5’-AMP induced hypometabolic state without the
observed mortality outcome. Thus, my research aim was to investigate the physical,
biochemical and physiological parameters that control the process of deep hypometabolism
in mice. The hypothesis was that by understanding these parameters, the limitations of the
non-hibernator’s ability to maintain deep hypometabolism for prolonged periods could be
expanded by administering key supplement(s). Through this expansion, we may allow nonhibernators to perform a deep hypometabolic process observed only in nature by hibernators.
At the biochemical level, we began by obtaining a detailed metabolic analysis of serum
metabolites of the animals at 4 distinct stages. These 4 stages, as defined by Heldmaier, are
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entrance, maintenance, arousal and euthermia. However, since our animals are induced, the
entrance samples were taken as euthermic samples prior to induction to establish a baseline
to compare the later samples. At the physiological level, the core body temperature and the
metabolic rate of the animals were examined via telemetry and oxygen consumption/carbon
dioxide production during these 4 stages (Figure 1). The oxygen consumption (VO2) graph
revealed 2 distinct phases of deep hypometabolism present in every mouse that is injected
with 5’-AMP. The first phase (PI) is the induction or entrance phase, portrayed by the steep
and rapid drop in VO2 from euthermic levels (~4000 ml /kg/h) to around 1500 ml/kg/h. The
second phase (PII), characterized by the gradual decline from 1500 ml/kg/h VO2 to about
300 ml /kg/h, is the stage in which deep hypometabolism is achieved, followed by the
maintenance phase. The arousal phase is characterized when the VO2 displays a steady
increase from the basement level reached during the maintenance phase where VO2
surpasses 2000 ml/kg/h. The recovery phase is started when the animal is back to euthermic
temperature with VO2 levels of ~ 4000 ml/kg/h. A telemetry device implanted in the mouse
allowed us to simultaneously monitor the relation between the core body temperature and
that animal’s oxygen consumption (VO2). At the physical level, the effect of environmental
temperature on the physiological response of the mice during the hypometabolic state was
investigated. My studies revealed several important conclusions: 1) The environmental
temperature plays a major role in modulating the outcome of deep hypometabolism. 2) The
dosage of 5’-AMP plays a key role only during the initial induction stage of
hypometabolism, but not its prolonged maintenance. 3) Our biochemical analysis revealed
that there are dramatic changes between the 4 behavioral stages in the flux of key
metabolites which play a role in glycolysis/gluconeogenesis, transamination, purine
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Figure 1. Normal mouse data of induced hypometabolism by 5’-AMP. The top graph
represents oxygen consumption (VO2) while the bottom is the correlated core body
temperature (CBT) graph. After an injection of 5’-AMP, the mouse exhibits a quick and
immediate drop in oxygen consumption (Phase 1) followed by a more gradual decrease
(Phase 2). The 4 stages that the blood samples were collected for the Metabolon study that
will be talked about later are labeled on the CBT graph.
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catabolism and bile acids but fatty acid metabolism is less pronounced. 4) My studies
investigate whether the supplementation of certain metabolites in combination with fluid
could extend the length of hypometabolism in the mice.
A brief introduction to purine metabolism is provided to give some perspective to the
fate of the 5’-AMP injected. The 5’-AMP that is used to induce hypometabolism is primarily
metabolized to Inosine monophosphate (IMP) via AMP deaminase while there is a minor
pathway that catabolizes 5’-AMP by dephosphorylation to adenosine using AMP
nucleotidase. The 5’-AMP is also salvaged via the adenylate equilibrium to form ADP by
utilizing ATP. Once 5’-AMP returned back to physiological levels, the ADP can then be
reconverted back to ATP through the adenylate equilibrium. We have experimental evidence
to indicate that the major pathway via AMP deaminase and the conversion to ADP are the
main events in metabolizing the 5’-AMP injected to induce this DH state.
Glucose is usually broken down via glycolysis ultimately producing pyruvate and lactate in
times of oxidative stress. The lactate can be recovered back to pyruvate by lactate
dehydrogenase once it is transported to the liver. The pyruvate feeds into the TCA cycle
after conversion to Acetyl-CoA. Throughout both of these processes, energy is stored as
NADH, FADH2 and ATP. However, in the red blood cells, glycolysis is the primary
biochemical process to generate NADH and ATP. Oxidative phophorylation in combination
with glycolysis and the TCA cycle help make glucose a very efficient producer of energy; 1
glucose molecule is accepted to make around 38 ATP after it is completely metabolized.
When the body is able, glucose is the preferred fuel source for its efficient ability to produce
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energy. However, there are instances when glucose in limited and other fuel sources must be
utilized. One of these alternative fuel sources comes from amino acid catabolism. Amino
acids are different in their structure from glucose due to the amine group they possess. For
the most part, both glucose and amino acids are hydrocarbons (consisting of hydrogen and
carbon atoms) and therefore can both be readily used to produce energy. The difference is
that the amine group on amino acids must be taken care of once it is free from its carbon
chain. This is primarily done by removal from the body through the urea cycle since
ammonia is highly toxic at high levels. Amino acids are described as either ketogenic
glucogenic or both based on where they are utilized in producing energy. Glucogenic amino
acids can generate net glucose when it is metabolized. In contrast ketogenic amino acids
may not generate net glucose. Most amino acids are both ketogenic and glucogenic. All the
amino acids except for leucine and lysine are glucogenic which means the carbon skeleton
of these amino acids can be used in the production of gluconeogenic precursons like
pyruvate and TCA cycle intermediates like oxaloacetate and alpha-ketoglutarate. The two
purely ketogenic amino acids above give rise to acetyl-CoA and acetoacetyl-CoA which can
produce energy via the TCA cycle however they cannot be used directly in gluconeogenesis.
Once the amine group is removed it must be discarded which is done mainly by the urea
cycle which is responsible for taking ammonia out of the cells and removing it after being
processed in the liver and filtered through the kidneys. The importance of these pathways
will be examined further throughout this body of work to give a better idea of the metabolic
changes occurring in the mice while in the DH state.

8

CHAPTER TWO
Methods

9

Female C57BL/6 mice from either Taconic Farms or Harlan were used in the current
studies; however, the induction of DH has been shown to be just as effective in male and
female mice. Fresh 9-12 week old mice were given a few weeks rest in our animal facilities
with a 12h/12h Light Dark (LD) cycle to adjust to their new environment before being used
for the proposed studies. In addition, mice that have undergone DH were rested for a few
weeks before being reused in order to allow them to regain any lost body weight from the
procedure.
The laboratory instrument used in the current studies is a reverse flow climate
controlled metabolic chamber from Columbus Instruments, USA. It is a temperaturecontrolled incubator with 16 individually monitored cages with their own access to food and
water. Each cage has its own monitoring device for oxygen consumption and CO2
measurements. The information is then stored in an on-board computer that also controls the
entire instrument.
First, an experimental regime was established to keep things consistent in order to
define the effects of changing the desired parameters. From previous experimentations
undertaken by the laboratory, it has been observed that a temperature at about 15oC was
desirable. Thus, the thermostat was set at 14.5oC; in the metabolic chamber, the ambient
temperature (Ta) at this setting is actually right around 15oC based on the readings from a
thermometer placed in the chamber. Mice are nocturnal, therefore experiments were initiated
at around 5 a.m. All mice were fasted for 12h but water is given ad labitum. For the fasting,
the mice are removed from their normal cage and put into a fresh cage with fresh bedding
and water. By putting them into a fresh cage, there is no possibility of food crumbs,
droppings or deposits from prior feedings on the floor that could be a source of food. It is
10

not known if fasting plays an intricate role in either the suppression and/or the survival of
the mice; it is done as a means to normalize the experiments and to eliminate unknown
variables that could have an impact on the proposed study. Before the mice are placed in
their respective cages in the metabolic chamber, they are weighed so the computational
software can calculate the appropriate measurements (VO2, VCO2, etc.) during the
experiment. Once the mice are in their respective cages, the experiment is set up by giving
the experiment a label or file name, inputting animal tag numbers and their weights for the
respective cages, and, when telemetry (Mini-Mitter Respironics, OR, USA) is used, the
associated telemetry chip number with that mouse is also entered. The machine is then
calibrated with a sample gas with predetermined concentrations of oxygen and carbon
dioxide, and the experiment is ready to begin collecting data. After a few initial readings
lasting for about 30 minutes to gather baselines of all the mice, hypometabolism is initiated
with an intraperitoneal injection containing freshly prepared 5’-AMP (Sigma catalog #
A1752-25G) [0.5 mg/g body weight] in 100uL saline. As will be demonstrated later, the 0.5
mg/gw is an efficient dose of initiating the deep hypometabolic process resulting from a 5’AMP titration. The saline is made from OmniPur tablets (EMD chemicals product code
6501). 1 tablet is dissolved per 100uL water for a 1X solution and then pH adjusted to 7.2
and autoclaved to sterilize. Before injection, the saline is filter sterilized (.22µm sterile
syringe filters from Fisherbrand No. 09-719A). The first injection of tested metabolite was
given 2 hours after the 5’-AMP injection chilled on a bucket of ice for 30 minutes prior. The
injections between the initial 5’-AMP injection and the injections after the temperature is
bumped up were all given chilled to administer a solution closer to that of their body
temperature. The metabolites that will be tested in this study are glucose (Sigma D – (+) –
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Glucose, G-8270), pyruvate (Sodium Pyruvate SigmaUltra P8574-100g), arginine (Acros
Organics, L(+)- Arginine 104991000) and alanine (B-Alanine Eastman 4638). The
injections were of a similar volume of saline as a control for each experiment. The
concentration of metabolite, volume injected and frequency of metabolite given would vary
depending on the hypothesis being tested. In addition, the Ta would be changed to test the
effects of temperature on arousal and to establish a rewarming protocol that would allow for
a safe return to euthermia after mice have been in DH for a prolonged period. Throughout
the experiment, if mice aroused they would be taken out into normal room temperature and
placed back into their original cages with food and water ad labitum. After the experiment
was concluded, all remaining mice would be removed and put into their respective cages to
be monitored for the next 1-2 days. If mice appeared to be in any discomfort, they were
euthanized after symptoms were observed and noted. All experiments were carried out in
accordance with protocols approved by the animal welfare committee at the UTHSC
medical school (HSC-AWC-06-078 and HSC-AWC-08-015).
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CHAPTER THREE
Results

13

Effect of 5’-AMP dosage on deep hypometabolism
We have been able to mimic the torpor process, in both metabolic rate depression
and body temperature depreciation, in our laboratory with the administration of 5’-AMP.
Previous studies by other members of the laboratory revealed that a deeper torpor state can
be attained if the mice given 5’-AMP are cooled to a lower core body temperature. This
deep torpor behavior, which we call deep hypometabolism (DH) or “suspended animation”
(SA) has physiological parameters such as core body temperature and metabolic rate based
on oxygen consumption that are much lower than natural torpor (Heldmaier et al., 2004). In
general, it was observed that when a mouse’s core body temperature (CBT) drops below
18oC, it lost the ability to right itself when laid on its side or back, thereby entering our DH
or SA state. The length of time the mice are usually maintained in the DH state is currently
about 3-9 hours on average.
To demonstrate that the 5’-AMP concentration is the initiator of the process and not
the driver responsible for prolonging deep hypometabolism, mice were injected with a single
dose of 5’-AMP ranging from 0mg to 1mg per gram body weight (mg/gw) and then kept in
Ta of about 15oC. As seen in Figure 2, the length of time in the deep hypometabolic state,
where core body temperature is below 17oC and VO2 is below 1000 ml/kg/h, is independent
of the amount of 5’-AMP used once an efficient dose (at least 0.5mg/gw) is reached that will
ensure entrance into deep hypometabolism at 15oC Ta. As discussed previously, each mouse
that is injected with 5’-AMP, regardless of the dose, exhibits the initial phase 1 drop in VO2
but the phase 2 maintenance of DH is not apparent when the dosage of 5’-AMP is
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A)

C)

B)

D)

Figure 2. 5’-AMP titration. Mice were injected with A) Saline, B) .1mg / gram body
weight (mg/gw), C) .5mg/gw and D) 1.0 mg/gw all at 15o ambient temperature (Ta). B) Also
shows the injection of 5’-AMP and the corresponding phase 1 and 2 (PI and PII) to show
that even low concentrations of 5’-AMP respond similarly and therefore the concentration is
only important to induce the process, not to prolong it. All VO2 readings are in hundreds.
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insufficient. This observation suggests that the concentration of 5’-AMP is necessary to
cross the threshold and initiate the process. Once the mouse enters DH, the timing of arousal
is not dependent on the dose of 5’-AMP used to induce DH. In addition, previous studies
from other members of the laboratory have investigated whether arousal could be
suppressed by re-injecting another dose of 5’-AMP. Logically, the process should be
repeatable until the investigator decides to end the experiment and allow the mouse to
arouse. However, what was observed was that suppression of arousal by additional injection
of 5’-AMP led to increased mortality. It was observed that mice in DH after 14h have high
mortality rate when arousal was suppressed by additional injections of 5’-AMP. The cause
of death remains unclear, although dehydration is one possibility. Therefore, dehydration as
a cause of death during prolonged DH was investigated.
Does giving saline during DH increase survival and help suppression of arousal?
Hibernators can spend weeks at a time in hibernation, which allows their bodies to
go without food and, more importantly, without water for longer periods than is normally
possible (Heldmaier et al., 2004). However, it has been observed that hibernators that
undergo bouts of arousal during winter rise to drink but not to eat during their episodes of
euthermia (McManus 1974). Since these mice are not natural hibernators, it was
hypothesized that they may need certain supplements to maintain their deep hypometabolic
state. The first supplement to test is the most important for sustaining life, water; but, in
order to keep electrolyte levels at physiological norms, saline instead of water was used for
these studies. The experiment was basic; one group of mice (n=8) received periodic
injections of saline; another group of mice (n=8) received mock injections, during which
they were taken out and handled, then subsequently returned to their cages. After about 18h
16

in DH, both groups of mice were aroused by raising the Ta to ~16oC. One of the mice from
the group not given fluid did rise before 12h and was excluded from the final analysis. The
findings from this experiment are as follows: 5 of the 8 mice given saline survived, although
2 of these 5 mice had aroused spontaneously from DH at about 14 h. Only 1 of the 7 mockinjected mice survived (Table 1). After 12h, no mock-injected mice aroused and none
survived. This experiment indicated that hydration for the mice in the DH state was
beneficial. However, given that about half of the animals did not survive, it suggests that
hydration alone is not enough. In addition, of the mice that died, some displayed apparent
neurological defects, such as involuntary movements after they had re-warmed, and they
were euthanized.
Fresh vs. reused mice
After performing multiple experiments, an apparent trend was observed between
arousal rate and whether the mice were fresh (animals that had not been injected with 5’AMP) or reused (mice that had been given 5’-AMP previously). Suppression, at the same
temperature, seemed to favor mice that had never been administered 5’-AMP over those that
had been used in an experiment regardless of whether this previous experiment was a week,
a month or even months ago. When these data sets were examined, it proved that my initial
observations were correct: the mice that were seeing 5’-AMP for the first time typically
have a much lower rate (15%) of early arousal (arousal before 12h) when saline is provided
after mice had entered DH. In contrast, mice that were being reused and had seen 5’-AMP
before have a much higher rate of early arousal (51%) (Table 2). It was noticed that many of
these early arousals appeared to be the heavier animals in the group. Therefore, the
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Saline injections while in DH

No Saline injections

5/8 mice survived after 12h

1/7 mice survived after 12h

Table 1. Saline vs. Non-Saline Mice. Each group (n=8) were used to test the importance of
saline. At ~15oC mice in the saline group were injected periodically while the non-saline
mice were handled similarly to the saline treated mice without receiving an injection. 1
mouse from the non-saline group came out before 12 hours and therefore was not included
in the final analysis.
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Fresh mice arousal rates

Reused mice arousal rates

(in first 12 hours)

(in first 12 hours)

Given saline

Given saline

3/20 = 15%

20/39 = 51%

Table 2. Arousal rates between fresh and reused mice. Arousal rates in fresh and reused
mice were examined to explore an observational trend. After examining the data, there
seems to be a preference for the fresh mice to stay down in DH after 12 hours. Experiments
were all run around 15oC with periodic injections of saline.
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relationship between mouse weight and the time of spontaneous early arousal with the
reused mice was examined. When the arousal time of the mice in DH given saline was
plotted against their body weight, a trend was visible (Figure 3). Smaller mice tend to stay
down longer than bigger mice. One possible explanation of this relationship could exist in
the cooling efficiency between the smaller and larger animals. The larger animals have a
smaller surface to volume ratio, which may not allow them to cool to a lower core body
temperature as the smaller ones, and therefore they may not have fallen into as deep DH as
the smaller mice. However, it is possible that other factors could be involved, since some of
the early arousal animals were small. Nevertheless, the data would suggest that larger mice
may need to be cooled in a slightly lower temperature than the smaller mice.
Does the circadian cycle have any influence on arousal?
The mice used in these experiments are typically housed in a 12h/12h light dark
(LD) cycle in the animal facilities. However, some studies on natural hibernators conduct
their research in 12h/12h Dark/Dark (DD) to coerce the animals into their hibernating bouts
(Heldmaier et al., 2004). To address whether this change in environmental signal was
important for preventing early arousal of mice in DH, a group of mice (n=16) with many
habitual early arousals was put in a DD cycle for 3 days prior to DH induction. An earlier
study with this group of mice when kept in an LD cycle showed that many were habitual
early risers (Figure 4). As can be seen from the graph, about half of the 16 mice came out
from DH during the first 12 hours. The same group of mice now maintained in a DD cycle
did not show a significant reduction of early arousal. The LD and DD results with this
group of mice revealed that the number of early arousals were similar at about 50% (Figure
4). Therefore, there is no apparent effect of the DD cycle on the suppression of early arousal.
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R2 = .379
p = .005
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Figure 3. Examination of relationship between weight and arousal time. 19 reused
saline mice were induced into DH and their arousal times were recorded and plotted against
their weight to examine if there is a trend. Whereas a trend was apparent, showing that
heavier mice tend to come out earlier than the lighter ones, some light ones also came out
early suggesting there are other factors influencing arousal other than weight. Statistical
analysis done by software from Wessa, 2008.
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Figure 4. Role of Circadian Cycle in suppressing arousal. The same 4 saline mice were
used once in a normal 12h:12h Light Dark (LD) cycle and then again in a 12h:12h Dark
Dark (DD) cycle weeks later to test if there was a benefit to doing our studies in DD instead
of LD. After examining the data, there did not seem to be any significant difference in
suppression of arousal.
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However, it was observed that in the few DD experiments that were run, the survival after
12 hours was impressive – 14 out of 16 mice that stayed beyond 12h survived. Many of
these were in DH for 18h or longer. This is an interesting observation that will need to be
explored further in the future.
Effects of environmental temperature on deep hypometabolism
The role played by environmental temperature in determining the length of the DH
state was investigated. Previous studies have suggested that environmental temperature is a
key exogenous factor in regulating hibernation (Al-Badry and Taha, 1982). Two groups of
mice (n=4) were given the same dose of 5’-AMP (.5mg/gw) but were maintained at different
ambient temperatures: 23oC and 15oC. Figure 5 shows the effects of 5’-AMP induced
hypometabolism at these two different ambient temperatures. The results show that the
length of time the animal spends in deep hypometabolism is much longer when the ambient
temperature is 15oC than at 23oC. Furthermore, the 15oC graph shows that the depth of DH
attained and the severity of metabolic suppression were increased at this lower temperature
when compared to the 23oC graph. Given that the same dose of 5’-AMP was used for both
groups of mice, it can be concluded that at the lower temperature, the DH is prolonged and
arousal further suppressed compared to the warmer Ta.
To further support these findings, an investigation was carried out to determine
whether arousal from DH could be suppressed completely by further lowering the Ta. To
exclude the possible contribution of individual mice variability, the same group of inbred
mice (n=5) was used in sequential fashion for this study. When given 5’-AMP (0.5mg/gw),
the same group of mice were maintained at ambient temperatures of 13.8oC, 13.6oC, 13.4oC
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Figure 5. Effects of Environmental Temperature on DH. Mice were injected with .5
mg/gw 5’-AMP and placed at 2 different environmental temperatures, ~23oC and ~15oC.
Each group also has the phase 1 and phase 2 of induction labeled to point out the differences
between the 2 temperatures. At 23oC, the phase 2 drop is short and approaches 1000 VO2
before the mouse starts to come out from DH about 2 hours later. However at 15oC, the
phase 2 drop is more pronounced and lower allowing the mice to stay in DH for up to ~10
hours. This experiment showed that the environmental temperature is the important factor in
suppressing arousal for the DH state.
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or 13.2oC. The VO2 graphs in Figure 6 show that there is a correlated linear relationship
between the arousal rate of these mice and the Ta. The suppression of arousal is evident; not
only do more mice stay down as the temperature is decreased, but the mice that come out do
so significantly later than at the warmer temperatures.
From these results, subsequent experiments with fresh mice using a Ta of 13.2oC
were undertaken. The suppression of arousal results were similar; however, the fresh mice
were met with an astonishingly high mortality rate after 12h (>95%) even when saline was
provided.

Therefore, this strategy for preventing early arousal in mice needs to be

investigated further.
In conclusion, the current investigation revealed that DH of mice can be induced by
5’-AMP. The amount of 5’-AMP only controls whether or not the mice will enter DH; the
Ta is the key parameter regulating the DH state. If kept at about 15 oC, mice will safely enter
DH and remain in such a state for about 3-9 hours following an injection of 5’-AMP of the
appropriate dose.
One objective of this research is to extend the limit of DH in the mice. The above
studies have shown that lowering the ambient temperature, giving injections of saline while
in DH and administering an additional injection of 5’-AMP at the first sign of arousal all
have significant drawbacks to their ability to extend the DH length. Primarily, it increases
the mortality rate when Ta is too low after the mice have stayed in DH for more than 14
hours, even when saline was given. Additional injection of 5’-AMP prevented normal
arousal but also enhanced mortality rate.
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Figure 6. Temperature Titration. A group of 5 mice were used in subsequent experiments
to establish a temperature that was beneficial to completely suppressing arousal. The
temperatures ranged from 13.8 – 13.2 in .2oC increments. The experiment showed that as the
temperature is decreased, arousal is delayed and in some cases inhibited altogether.
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Changes in metabolites during various stages of 5’-AMP mediated hypometablism
To gather some insight into the changes of the metabolic state when mice undergo
deep hypometabolism, serum was obtained from mice (each group n=8 mice) during the 4
stages; euthermia (control), deep hypometabolism (SA), arousal (reverse flip) and full
recovery (recovery). These serum samples were examined at a commercial company
specializing in metabolite analysis (METABOLOM). Figure 7 illustrates the 4 different
behavioral stages where the mice were sacrificed and their serum collected and how the
metabolomic data was analyzed. For each group, the value of each metabolite is the average
obtained from 8 mice. For each of the metabolites, the average value at euthermia is
arbitrarily set at 1. The fold change in the DH, arousal and recovery is relative to the value
obtained for euthermia. Therefore, a value of 1 indicates no change, a higher value indicates
an increase and a value less than 1 indicates a decrease, all relative to euthermic levels.
Is glucose important in suppressing arousal?
The findings from the metabolomic analysis indicate that serum glucose was
maintained at an elevated level for a prolonged period during DH (Figure 8). It has also
been noted that a genetic shift from glycogen and fatty acid synthesis to gluconeogenesis is
occurring in hibernating arctic ground squirrels, suggesting the animals are trying to provide
themselves with increasing amounts of available glucose during their hibernation bouts
(Yan et al., 2008). In addition, previous observations from the laboratory suggest that
arousal coincides with decreased blood glucose and the activated expression of pro-colipase
in the liver and other peripheral organs (Zhang et al., 2006). The metabolomic study also
shows that glucose decreases between the DH state and arousal (reverse flip) state. It has
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Example of Metabolon Data
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Figure 7. Example of Metabolon Data. This is an example of how to read future figures
that came from a Metabolomic Study done by Dr. Zhaoyang Zhao. Each group of mice
(n=8) had blood collected at the 4 time points which were labeled in Figure 1. Control was
prior to induction of DH, SA state is while in DH, Rev Flip is upon spontaneous arousal, and
Recover is after the mice have returned to euthermia.
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Glucose metabolism
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Figure 8. Glucose Metabolon data. Shows the levels of Glucose and Glucose-6-Phosphate
through the different stages of DH. As can be seen, both are highly elevated from control
groups with a slight drop in glucose between DH (SA State) and spontaneous arousal (Rev
Flip) which could signify an inability to produce large amounts of glucose anymore
signaling arousal to the mouse.
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further been suggested that hibernating ground squirrels use the increased availability of
glucose to fuel their body’s non-shivering thermogenesis (NST) maintaining their body at
the right temperature while in hibernation (Yan et al., 2008). Together, this information led
to a hypothesis that the mice may arouse when they can no longer produce the large amounts
of glucose they need to sustain themselves in the DH state. Thus, whether injecting glucose
could suppress arousal better than saline alone was investigated. Two groups of mice (n=3)
were injected with similar amounts of saline at the same intervals; however, one group
received glucose (20mg) at the 2-hour injection. After that injection, subsequent injections
were solely saline for both groups. The experiments revealed that two mice from each group
came out from DH at roughly 8-9 hours while the last of the saline group came out around
12-13 hours and the last of the glucose group around 20 hours after an increase in the
temperature. Overall, the studies revealed that there was no major differential outcome in
preventing early arousal whether the mice received saline or glucose (Figure 9). Additional
experiments confirmed the conclusion that the early arousal rates continued to be about
equal between glucose-injected mice and saline-injected mice. One possible reason for the
elevated blood glucose is that the overall rate of glycolysis had been slowed at hexokinase
and phosphofructose kinase, since there is also a 4-fold build-up of glucose 6-phosphate and
fructose 6-phosphate according to the Metabolomic data.
Is pyruvate important for suppressing arousal?
Consistent with a reduced rate of glycolysis, the Metabolomic data indicated
extremely low pyruvate and lactate levels in the DH state (Figure 10). Lactate is utilized by
the liver to make pyruvate. Pyruvate is normally converted by pyruvate dyhydrogenase to
acetyl-CoA, a necessary input for the TCA cycle. However, ground squirrels undergoing
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Figure 9. Glucose experiment. 2 groups of mice (n=3) were either given an injection of
glucose or pure saline around 2 hours into the experiment followed by subsequent injections
of saline. There appeared to be no benefit in suppressing arousal by injecting glucose over
just saline.
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Figure 10. Glycolytic Products Reduced in DH. Metabolon data shows that there is a
decrease in the glycolytic products of pyruvate and lactate while there is also an increase in
glycolytic intermediates. This would point to either a reduction in glycolysis or an increase
in gluconeogenesis.
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torpor have shown an overexpression of Pdk4 (pyruvate dehydrogenase kinase isoform 4),
an enzyme that deactivates pyruvate dyhydydrogenase, blocking the conversion of pyruvate
to acetyl-CoA (Yan et al., 2008). In addition, in the liver, pyruvate can also be converted
into oxaloacetate (OAA) then to malate which can exit the mitochondria and be used for
gluconeogenesis by producing phosphoenolpyruvate. Interestingly, it has been recently
shown that a key enzyme for the aforementioned process, Phosphoenolpyruvate
carboxykinase (Pck1), is overexpressed in hibernating bears while some glycolytic enzymes
are underexpressed, also hinting toward a state of gluconeogensis during hibernation
(Fedorov et al., 2009). It is also interesting that some TCA cycle intermediates, such as αketoglutarate, isocitrate and succinate, were also dramatically decreased (Figure 11).
Slowing the TCA cycle causes the body to resort to a glycolytic state for ATP generation.
Glycolysis is highly inefficient compared to oxidative phosphorylation where ATP is
produced from the electron transport chain.
It is possible that the reduction in the TCA cycle intermediates could be a direct
result of the decrease in pyruvate availability, since its absence could cause a slowdown in
acetyl-CoA production that in turn would limit the amount available for the TCA cycle.
Thus, supplemental pyruvate injected into the mice may restart the TCA cycle, which will in
turn enhance the oxidative phosphorylation process allowing the mice to produce energy
much more efficiently. Therefore, whether giving pyruvate to mice in DH might suppress
arousal and prolong the amount of time down was investigated. Two groups of mice (n=3)
were given either saline or pyruvate after they had entered DH after treatment with 5’-AMP.
Similarly to the glucose experiment, the pyruvate group got the supplemental injection
(20mg) at 2h and saline at subsequent injections. The study showed that there was no
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Figure 11. TCA cycle intermediates reduced in DH. Metabolon data shows that there is a
decrease in a few TCA cycle intermediates hinting at a slowing down of the TCA cycle in
the DH state.
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significant suppression of early arousal between the mice given saline and those given
pyruvate (Figure 12). This result was fairly similar to that of the glucose experiment;
however, the 3 mice from each group came out before or around 12 hours. The outcome of
this experiment and several other subsequent larger studies indicated that pyruvate did not
alter the level of early arousal, nor did it result in better survival compared with saline when
animals stayed down for longer than 12 hours. Thus, it is concluded that a deficiency in
pyruvate was not a major factor in regulating early arousal.
Are amino acids important to suppressing arousal?
Additional reevaluation of the Metabolomic data revealed that the mice had a very high
level of glucose and glucose 6-phosphate while in DH. In the liver, glucose 6-phosphate is
converted to glucose. However, in the muscle glucose and glucose 6-phosphate can be
converted to glycogen for storage or used in glycolysis to generate ATP. Furthermore,
during DH, other glycolytic intermediates like phosphoenolpyruvate (PEP) were increased
(Figure 13). However, the products of glycolysis such as pyruvate and lactate were
decreased. The increase in glycolytic intermediates, combined with the decrease in pyruvate
and lactate, suggested that the mice were possibly undergoing gluconeogenesis or that
glycolysis was highly reduced while in the DH state. Similarly, it has been shown recently
that arctic ground squirrels have increased gene expression of gluconeogenic enzymes in
their torpor state when compared to euthermic levels (Yan et al., 2008). Lactate is normally
produced in the muscle when oxidative phosphorylation cannot sustain the demand for
cellular ATP leading to anaerobic ATP generation via glycolysis. However, the mice
displayed much lower levels of lactate, suggesting that there is actually very little demand
for glycolysis. In addition, the extremely low levels of pyruvate also suggested that the level
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Figure 12. Pyruvate Experiment. 2 groups of mice (n=3) were either given pyruvate or
saline 2 hours into the experiment followed by saline for all mice in following injections.
This experiment shows, similarly to glucose, that there is no real difference in arousal rates
between saline and pyruvate injected mice.
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Figure 13. Later glycolytic intermediates increased in DH. Metabolon data shows an
increase in late stage glycolytic intermediates.
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of glycolysis was low. This may explain why blood glucose and glucose 6-phospate is
significantly enhanced in the mice during DH.
If the hypothesis that the mice are in a gluconeogenic state is correct, then synthesis
of glucose will require the availability of carbon skeletons, which are provided by amino
acids, lactate or glycerol. The metabolomic data indicated that the catabolites of amino
acids were significantly increased during DH suggesting that amino acids were indeed
catabolized (Figure 14). Some genes in the liver, Glud1 and Got2, responsible for amino
acid catabolism have also been shown to be overexpressed during torpor in ground squirrels
(Yang et al., 2008). Therefore, whether giving amino acids to supplement the energy
production would help suppress arousal was investigated.
In order to determine which of the amino acids to use, a serum panel was run of
amino acid levels in normal mice (n=2), mice in DH (n=2) and mice at arousal (n=2)
through a commercial service laboratory at Baylor College of Medicine. This study revealed
that the mice in DH and at arousal were low in two amino acids, histidine and arginine,
while the rest of the amino acids were greatly enhanced or not affected during DH and at
arousal compared with euthermic control (Table 3). Table 3 shows the complete panel with
the two reduced amino acids indicated by the arrow. Each group of mice (euthermic, in DH
and at arousal) had 2 sample points with the average value taken of those points and
displayed in bold below the group. The most significant reduction is arginine. Why
arginine?
To answer this question, the biological pathways that these amino acids are involved
in were examined; importantly, arginine plays an intricate role in the urea cycle (Figure 15).
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Figure 14. Amino Acid catabolites are increased in DH. Metabolon data shows an
increase in amino acid catabolic products in DH.
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Table 3. Amino Acid assay. An amino acid assay from mouse serum samples (n=2) taken
at 3 different stages throughout DH. First stage was euthermic (normal), second was while
in DH (SA) and the third was at initial sign of spontaneous arousal. The 2 amino acids that
are decreased are pointed out (histidiine and arginine).
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Urea Cycle

Walker 2009

Figure 15. Urea cycle. NAGS, N-acetylglutamate synthetase; CPS1, carbamylphosphate
synthetase 1; OTC, ornithine transcarbamylase; AS, argininosuccinate synthetase; AL,
argininosuccinate lyase; citrin, mitochondrial aspartate-glutamate carrier; ornithine transport
system. The urea cycle displays the intricate role that arginine plays in the functionality of
the entire cycle.

The reduction in the availability of arginine may compromise the urea cycle’s ability to
release urea and regenerate ornithine, which is essential to transport the NH2+ group on the
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carbarmoyl-phosphate out of the mitochondria by forming citrulline. Therefore, a shortage
of arginine could significantly reduce the animal’s ability to deal with an increased ammonia
build up generated by transamination of amino acids (Figure 16). Since it requires more
energy to produce uric acid than ammonia, the natural tendency would leave the ammonia
groups as ammonia. Ammonia is highly reactive with lipids in plasma membranes, resulting
in severe cellular damage; however, it is only toxic in the brain (Walker, 2009). Hibernating
bears have means to recycle their nitrogenous waste, decreasing their urea cycle outputs
(Barboza et al., 1997). The decrease in activity of the urea cycle noticed in the bears has
also been shown in hibernating ground squirrels (Williams et al., 2005), which suggests all
natural hibernators have an ability to suppress urea formation while in a hibernation-like
state. Since these mice are not natural hibernators, they potentially do not possess these
mechanisms to prevent the build-up of ammonia. Because of this possible inability to handle
increases of ammonia while in DH, the mouse’s ability to stay in DH for a prolonged time
may be limited. It is possible that mice spontaneously arouse to handle the build-up of
ammonia. To help gain insight into this theory, a colleague (Isadora Susan Daniels, Ph.D.
student) in the lab ran a blood urea nitrogen assay (QuantiChrom™ Urea Assay Kit, DIUR500 from Bioassay Systems) for mice throughout the DH process; the time points (n=20)
were pre-injection, 1 hour into DH, 4h into DH, spontaneous arousal (RF), shivering, and
return to euthermic temperature (Figure 17). The data shows a steady increase over the
course of DH, with a decrease at the spontaneous arousal stage. This could suggest that the
urea cycle is indeed shut down in the DH process, causing an accumulation of nitrogen in
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Amino Acid Breakdown

http://instruct1.cit.cornell.edu/courses/biog105/p
ages/demos/105/unit7/media/nitrogenouswastes.
1.jpg

Figure 16. Breakdown pathways of amino acids. Shows possible options in removing
ammonia after the breakdown of amino acids. In the case of our mice, which it is
hypothesized the urea cycle is compromised during DH, this figure suggests that the
ammonia being produced would stay as free ammonia causing a build-up in vivo.
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Figure 17. Accumulation of blood urea nitrogen. Corroborating evidence from a member
in the laboratory shows an increase of blood urea nitrogen (BUN) levels throughout the DH
process with a slight decrease at the signal of spontaneous arousal (RF). Blood sampes were
taken from mice (n=20) in the different stages of DH (SA). This data lends some merit to
our hypothesis of the urea cycle being compromised from the decrease in arginine
throughout the DH process.
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the blood. The spontaneous arousal could be a signal to the body that blood nitrogen levels
are reaching a critical mass and the animal must come out to get rid of the waste. This result
supported our theory and thus, it was investigated whether supplementing arginine could
suppress early arousal. Two groups of mice (n=4) were used; one received an injection of
arginine (2mg) at the 2h injection (same as pyruvate and glucose), and subsequent injections
were pure saline for the rest of the experiment. Figure 18 shows that the effect of arginine
was striking. It was observed that 3 of the 4 mice that received arginine did not arouse early.
None of the saline- injected mice (n = 4) displayed a similar ability to prolong DH. Not only
was the early arousal suppressed, the survival after 12 hours was improved. The three
arginine-injected mice that stayed down after 12h were able to stay in DH for up to 24
hours, and all survived without complications.
The hypothesis was made that the arginine had repaired the urea cycle; it has been
shown previously that arginine can be used as an alternate pathway treatment to repair some
urea cycle deficiencies in human patients (Walker, 2009). To investigate this hypothesis,
another amino acid, alanine, was tested for a similar outcome. The transamination of alanine
with α-ketoglutarate via alanine transaminase is directly converted into glutamate and
pyruvate, one of the metabolites that is in very short supply during DH (Strobel 2007). If
the mice given alanine showed similar results to the arginine mice, it could be inferred that it
was not the urea cycle being repaired but simply that an amino acid fuel source was what the
mice needed. A group of 7 mice (4 alanine, 3 saline) were given their respective injections
2h into the experiment. This experiment showed that giving alanine to mice only slightly
increased the amount of time mice stayed in DH compared to saline-injected animals
(Figure 19). However, the suppression was not nearly as dramatic as the arginine, and most
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Figure 18. Arginine vs. saline experiment. 2 groups of mice (n=4) were given either saline
or an injection of arginine 2 hours into the experiment and subsequent saline injections to
both groups. This experiment suggested that arginine was beneficial in suppressing arousal
and of those it suppressed the survival was better. The 4 saline mice all came out before or at
12 hours whereas only 1 arginine mouse came out before 12 hours and one lasted almost 24
hours in DH.
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Figure 19. Alanine vs. saline experiment. 2 groups of mice (n=4 alanine and n=3 saline)
were given either saline or an injection of alanine 2 hours into the experiment. The alanine
injected animals lasted slightly longer in DH however most still aroused by 12 hours and the
one that stayed down more than 15 hours wound up coming out with fatal side effects.
Suggested that alanine could not be used in suppressing arousal.
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of the mice still came out as early arousals, meaning arousal was not completely suppressed.
Also, those that stayed down for more than 14-15 hours came out with unwanted side effects
that affected their long term viability. These side effects include an inability to balance
properly and constant shaking; these animals were euthanized. Descriptions of these side
effects have been noted before in human cases dealing with arginase deficiencies (Brusilow
et al., 2001), and it has also been noted that urea cycle deficiencies in general can lead to
brain damage (Walker, 2009). These experiments suggested that the amino acids are
important, however arginine’s effect on the urea cycle appears to be crucial for both
suppression and survival. Normally small hibernating rodents use their amino acids to
produce energy through gluconeogenesis and the TCA cycle since these amino acids are not
producing urea (Yang et al., 2008), however since these mice are being induced into this
torpor-like state and do not prepare their bodies like typical hibernating animals (Al-Badry
and Taha, 1982), the arginine given may aid in removing the nitrogenous waste that is
being produced. In order to confirm arginine’s importance, the successful experiment’s
parameters were repeated with all 16 mice given arginine (2mg). They all received an
injection at 2h into DH and another arginine injection at the 28h mark for the mice still
down. The intermediate injection was saline. Figure 20 shows that the results from the
initial experiment were highly replicable and further proof of the significance and
effectiveness arginine has on the arousal rates and survival of the mice. All mice but 2
stayed down for the initial 12 hour period and upon an increase in temperature and removal,
all mice came out and survived. One unfortunate fatality was due to human error a few days
post experiment; however, I believe it could have been readily prevented if the right
precautions had been taken. In addition, this study revealed that 2 mice were in DH for 30
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Figure 20. Arginine experiment. All mice (n=16) were given an injection of arginine 2
hours into the experiment. 2 mice came out in the first 12h however suppression was largely
suppressed and there was 100% survival even for those mice that stayed down 28+ hours.
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hours and when they were gradually rewarmed, they returned to euthermic state without
obvious disabilities. Typically, from observations of many past experiments, if mice stay in
DH after the temperature is bumped up they do not survive even for a day. These mice,
however, were viable and appear normal even after 3 weeks of monitoring after undergoing
this 30-hour DH. This experiment has since been repeated and similar results were obtained.
Therefore, it has been concluded that at least part of the reason for arousal is tied to a buildup of ammonia in vivo. The ammonia build up is a consequence of the transamination of
amino acids as the animal in DH is undergoing gluconeogenesis. A shortage of arginine
compromised the animal’s ability to safely remove the ammonia through the urea cycle. By
arousing early, the gluconeogenic process would slow as the normal oxidative
phosphorylation process to generate ATP returns and the production of ammonia is reduced.
Is any single metabolite better than the rest?
After a multitude of experiments using the metabolites above, all the data was pooled
together and examined. From this data, 2 tables were created, providing an in-depth analysis.
The first table shows the various metabolites and their benefit to suppress early arousal
(Table 4). Even though some sample sizes were smaller than others, one metabolite stands
out: arginine. Its 14% total arousal rate is half that of the next closest (pyruvate) and
significantly less than saline alone (39%). The second table shows the overall survival after
being in DH for 12 hours for the different groups of mice (Table 5). This is the most
interesting data of all. While most of the metabolites are right around saline (58% saline,
64% glucose and 67% pyruvate), once again arginine is superior. The difference is
phenomenal. Of the arginine mice that stayed down 12 hours or more, 94% survived. This
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Metabolite

Arousal before 12h

Saline

23/59 = 39%

Glucose

5/16 = 31%

Pyruvate

25/89 = 28%

Arginine

6/42 = 14%

Table 4. Metabolite benefit for suppressing arousal. Table shows the metabolite and their
corresponding percentage of mice that were early arousals (before 12h). Arginine had the
best at 14% which was half of the next closest and almost a third of saline.
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Metabolite

Overall Survival after
12h

Saline

21/36 = 58%

Glucose

7/11 = 64%

Pyruvate

43/64 = 67%

Arginine

34/36 = 94%

Table 5. Metabolite benefit for survival after 12h. Table shows the metabolite and their
corresponding percentage of mice that survived after 12 hours in DH. Arginine is a clear
favorite at 94%. The 2 deaths in the arginine group are believed to have been preventable
since they were both due to human error during or after the experiment.
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number would have been 100%; however; the two animals that did succumb died due to
human error after having aroused from DH.
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CHAPTER FOUR
Discussion
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The fate of the 5’-AMP injected is the focal point around this study. Our studies
revealed that 5’-AMP can be disposed of in 2 different ways; it can be catabolized to IMP
and/or adenosine or it can be converted via the adenylate equilibrium to 2 ADP by
combining with an ATP. The latter is the aspect believed to be important in the DH initiation
process. Since ATP is essential for maintaining cellular activity levels at their optimum, by
injecting AMP and removing ATP it would cause a slowdown in cellular functional levels
throughout the body. Where this could possibly be of the utmost importance is in the red
blood cells where their sole source of energy is the ATP dependant process of glycolysis.
Our studies revealed that the red blood cells take up 5’-AMP readily. In turn, the increased
intracellular 5’-AMP will force the adenylate equilibrium to form 2ADP utilizing the
cellular ATP pool decreasing the level of intracellular ATP levels. Reducing ATP levels will
affect glycolysis at two critical steps where ATP is required. The first is at hexokinase where
glucose is converted to glucose 6 phosphate. The second is at phosphofructokinase which
converts fructose 6 phosphate to fructose 1,6 bisphosphate. The observed rise in glucose,
glucose 6-phosphate and fructose 6-phosphate is consistent with a stalling of glycolysis at
hexokiase and at phosphofructokinase. Metabolic modeling studies have shown that a
decrease in ATP production in the RBC will lead to an increased production of 2,3
bisphosphoglycerate causing an increase in oxygen’s disassociation with hemoglobin. This
is consistent with the phase I profile where a rapid decline in oxygen consumption was
observed and is independent of the animal’s core body temperature and the dosage of 5’AMP given. In turn, the decrease in oxygen transport will slow down peripheral cell’s
metabolic needs by reducing oxygen availability. When the body cools, the demand for
oxygen also decreases thereby creating and interdependent loop between metabolic need and
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oxygen availability. This could explain the phase II profile where oxygen consumption was
linked to the animal’s body temperature.
These investigations of how the arousal process can be controlled have revealed
several interesting findings. If no fluid is provided, very few mice will stay in the deep
hypometabolic state beyond 12h under a permissive arousal temperature (Ta of 15oC). We
classified arousal before 12h as early arousal for the remainder of this discussion. If arousal
is suppressed by lowering the Ta to 13.2oC, then the mortality rate is increased if arousal
from deep hypometabolism is blocked for more than 12h. When saline is provided during
the DH state under Ta of 15oC, about 40% of the mice would be early arousals but,
significantly, about 60% of the mice can remain in DH longer than 12h. It was observed that
freshly bought mice that have not seen 5’-AMP previously have an early arousal rate of 15%
compared with 50% for reused mice. Given that the reused mice were typically heavier, we
investigated whether there was a relationship between the size of the mice and early arousal.
Plotting the weight of the mice against its arousal time revealed a relationship between early
arousal and the size of the animals. However, some of the smaller mice also displayed early
arousal, suggesting that weight and size alone cannot explain early arousal and endogenous
factor(s) are likely involved in the triggering of arousal.
While giving saline alone suppressed arousal for about half the mice in our study
group (combining new and reused mice), mortality rate is still about 40% of those that
stayed in DH longer than 12h. Whether optimizing the amount of fluid given over a 24h
period could reduce this mortality rate is unclear. Rather, it was hypothesized that fluid
alone is not enough to prevent death in mice that remain in DH longer than 12h. Through
metabolic studies that have identified changes in metabolites, a series of experiments were
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explored to test the usefulness of glucose (highly elevated in DH) and pyruvate (highly
decreased in DH) in suppressing arousal. Giving glucose to mice (20mg/inj) had a 31% early
arousal rate and about a 64% survival rate for the mice that stayed in DH longer than 12h.
This was not much better than giving saline to the mice. It indicated that glucose is neither a
major regulator of early arousal nor a metabolite that could improve survival when DH was
prolonged.
Pyruvate is slightly better than glucose (28% versus 31% early arousal rate) at
suppressing early arousal. About 67% of the mice given pyruvate that stayed in DH longer
than 12h survived; this number too was right around that of glucose. The outcomes for
pyruvate, glucose and saline were very similar in suppression of early arousal and overall
survival rate after DH longer than 12 h.
To date, the most promising metabolite that showed a major differential outcome in
suppression of early arousal and decreased mortality of mice in DH after 12h is the amino
acid arginine. Mice given arginine have the lowest level of early arousal (14%) and
mortality rate of mice in DH longer than 12h (6%). In fact, we have 3 mice that were in DH
for 30h and they all survived without apparent neurological damage. We have attributed this
success to arginine’s role in the urea cycle; however, arginine is also a key component in
creatine production and in nitric oxide production (Walker, 2009). The urea cycle and nitric
oxide pathway actually have many other intermediates and enzymes in common other than
just arginine (M.A. Neill et al., 2009). The urea cycle and NO pathway share arginine,
citruline,

argininosuccinate,

aspartate,

argininosuccinate

synthetase

(AS)

and

argininosuccinate lyase (AL) as well as a transporter, Citrin. Whereas the urea cycle has
parts in both the cytoplasm and the mitochondria, NO production takes place solely in the
57

cytoplasm. From our current studies, it appears that the urea cycle is the key player in the
survival and long term DH of our mice. However since the urea cycle and the NO pathway
are intertwined and seem to regulate each other (M.A. Neill et al., 2009), we will have to
examine both pathways to clarify their contribution to suppressing arousal. It has been
hypothesized that short term regulation of the urea cycle takes place in the mitochondria at
the enzyme CPS1 (Carbamoyl Phosphate Synthetase I), which is responsible for taking the
ammonia groups out of the mitochondria and transferring them into the urea cycle when
carbamoyl phosphate combines with ornithine (Walker, 2009). This enzyme has also been
shown to be down regulated in hibernating bears (Fedorov et al., 2009). Since arginine
plays a role not only directly in the urea cycle but also in the formation of a cofactor, NAGS,
of carbamoyl phosphate production (Walker, 2009), if arginine is reduced as it is in our
model, it would shut down both the shuttling out of ammonia from the mitochondria and the
production of urea. In the future, there are proposed studies to investigate enzymatic genes
of the urea cycle to determine which, if any, genes are being down regulated and/or up
regulated throughout our DH process. There have been studies that show supplemental
arginine, in instances of increased arginase activity that had led to human diseases such as
asthma and pulmonary arterial hypertension, has been beneficial for treatment (Morris et
al., 2008). There are other treatments besides arginine that have been effective in treating
urea cycle deficiencies via alternate pathways (Walker, 2009), but it has been suggested that
arginine may have advantages over other drugs (Jobgen et al., 2006). For future
investigations, we plan to inject these drugs (Sodium Benzoate and/or Sodium
Phenybutarate), or citruline (Walker, 2009) as it removes an ammonia group while also
getting converted to arginine which could help replace the reduced amount of arginine in
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vivo. Such studies, if successful in prolonging arousal, would give support to our current
findings that the inability to regulate ammonia is the primary cause for early arousal and
mortality if DH is prolonged.
After considering the urea cycle and its role, we must also examine the NO pathway
for its redundancy in intermediates and enzymes with the urea cycle. The production of NO
has numerous vital biological roles (Nathan, 1992) as it has 3 differentially expressed
isoforms: the endothelial (eNOS) isoform primarily regulates vascular tone, the inducible
(iNOS) isoform is mainly present in inflammatory and infectious conditions, and the
neuronal (nNOS) isoform is mainly in neuronal tissue acting as a signaling molecule (M.A.
Neill et al., 2009). It has also been suggested that NO plays a role in regulating nutrient
metabolism in almost all types of mammalian cells and tissues (Jobgen et al., 2006)
whether it is used in the cell that produces it or whether the NO gets taken up by the red
blood cells and transported to distant target cells (Stamler and Meissner, 2001). The
synthesis of NO requires more inputs than just arginine; it also requires tetrahydrobiopterin
(BH4), NADPH, Ca2+, calmodulin, FMN and FAD (Wu and Morris, 1998). NADPH and
calmodulin are need to give the NOS isoforms enzymatic activity while the Arginine, BH4
and heme are all used as promoters and stabilizers (Wu and Meininger, 2002). Since NO is
a highly reactive free radical species, it can have various affects depending on the
concentration (Jobgen et al., 2006). At physiological levels, NO stimulates glucose uptake
and oxidation, fatty acid oxidation, mitochondrial biogenesis, while enhancing lipolysis and
ATP concentration and inhibiting synthesis of glucose, glycogen and fat (Jobgen et al.,
2006). However if physiological levels are exceeded, it can disrupt the electron transport
chain (ETC), resulting in reduced ATP from oxidative phosphorylation and causing an
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increase in glycolysis to produce the required ATP. High levels of NO also decrease protein
synthesis while increasing amino acid catabolism (Jobgen et al., 2006). Since the NO
pathway and urea cycle are dependent upon each other, they must have mechanisms in place
to regulate one another and provide feedback to make sure the NO pathway does not exceed
the physiological levels and become a detriment to the cells. It has been suggested that NO
may reduce expression of urea cycle enzymes and urea synthesis from ammonia while
inhibiting amino acid oxidation in the liver and increasing the amount of dietary amino acids
released into the circulation (Jobgen et al., 2006). In order to keep a balance on the NO
production, the urea cycle can increase its rate in order to limit necessary substrates like
arginine (M.A. Neill et al., 2009). These feedback mechanisms appear to be crucial in
keeping each other in check. While it has been shown that arginine increases transcription of
NOS and NO production (Jobgen et al., 2006), if our mice were running out of arginine, it
was assumed these pathways would also be shut down in addition to the urea cycle.
Supplying arginine has been shown to have numerous effects on both humans and test
animals. In diabetic rats, it has been shown to reduce plasma levels of glucose, fatty acids
and triglycerides (Jobgen et al., 2006) while also reducing fat mass and showing promise in
uses for treating metabolic disorder (Flynn et al., 2002). In humans, it has been shown to
increase insulin sensitivity (Jobgen et al., 2006). Therefore, it has been hypothesized that
supplementing arginine, and maybe even citruline, might be able to help in treating
metabolic disorder (Jobgen et al., 2006) as well as potentially saving our mice. These are
testable hypothesis for future studies.
In summary, the following is what is believed to be occurring in this hypometabolic
model. After induction by injection of 5’-AMP and placement at ~15oC Ta the urea cycle is
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slowed and possibly halted due to a depletion of arginine levels. Therefore, the animals’
ability to remove ammonia from the body is deficient, leading to a build-up of free ammonia
in the blood. The spontaneous arousal that is seen is probably due to a critical limit in
ammonia levels in the blood acting as a signal to the animal to arouse or die. Therefore, by
supplementing the various other metabolites, we were not addressing the critical problem
that existed while the animals were in DH and that is why the other metabolites did not
work. Only once the urea cycle’s importance and in vivo arginine levels were addressed did
the mice start to prolong their time down in DH safely and consistently.
For future experiments, there are a few directions to test the various ideas to support
our current data. The urea cycle enzymes should be compared between DH, euthermia and
arousal to see if there are any changes. Citruline, Sodium Benzoate and/or Sodium
Phenybutarate can be substituted for arginine to evaluate if it is in fact the urea cycle
(Walker, 2009). If these treatments have similar effects to the arginine, that would point to
the urea cycle as being deficient in our mouse model. We can also take blood ammonia
levels during a time course throughout the DH process to see if there is an accumulation of
free ammonia as time elapses. Unlike the previous data which measured blood nitrogen
levels, this measurement would be solely for free ammonia and not total nitrogen levels. To
test whether the NO pathway is the reason for the arousal and the lack of long-term survival,
previous studies have used NO donors to treat NO deficiencies caused by an arginine
shortage (Morris et al., 2008). By giving one or more of these donors to our mice, if the
outcome is similar to the arginine experiments, we could suggest that the shortage of
arginine and the consequences of our DH state were impacting the NOS pathways and not
the urea cycle.
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